Microarousal

Micro-awakenings in infants typically occur every 45–60 minutes, reflecting the normal length of a baby’s sleep cycle.^[1]

Microarousal, also known as micro-awakening, refers to brief, often sub-second interruptions of sleep characterized by partial cortical activation without full consciousness. These transient arousals can occur during any sleep stage and are typically detectable through electroencephalography (EEG) as short bursts of brain activity.^[2]

Micro-awakenings are very short periods when the brain becomes partially awake between sleep cycles. During these moments, adults often adjust their position or move slightly before returning to sleep, often without any conscious awareness.^[1] Micro-arousals play an important role in sleep fragmentation and are associated with sleep disorders, such as obstructive sleep apnea, as well as with cognitive performance and daytime alertness.^[3][4]

Research and clinical perspectives

A microarousal is a brief episode of increased brain activity during sleep that is usually insufficient to fully awaken an individual. Microarousals can be triggered by sensory disturbances, including fluctuations in blood pressure or heart rate, as well as environmental noise. When occurring excessively, microarousals can fragment sleep, producing effects similar to sleep deprivation or restriction, such as emotional dysregulation, cognitive impairment, and social withdrawal. Frequent microarousals are also a common feature of certain neurological disorders, including depression, and of respiratory conditions such as obstructive sleep apnoea (OSA).^[2] In infants and young children, sleep cycles are shorter and include a higher proportion of light sleep. As a result, micro-awakenings occur more frequently, and children may have difficulty falling back asleep on their own, often waking and crying during the night.^[1]

In a 2024 Chinese study, the average sleep efficiency was about 98%. Participants experienced roughly 47 microarousals lasting at least 3 seconds per night. Of these, about 26 lasted at least 5 seconds, 19 lasted at least 7 seconds, and 13 lasted at least 9 seconds on average. The minimum duration required to define a microarousal has been a topic of ongoing discussion. Although a 3-second minimum duration was established by the American Sleep Disorders Association in 1992, this criterion has been criticized for low inter-scorer reliability. Some researchers have suggested that longer durations may more accurately characterize microarousals and provide greater clinical utility in assessing cognitive impairment in patients with obstructive sleep apnoea (OSA). Long microarousals lasting 15 to 60 seconds correlated more strongly with subjective sleepiness than short microarousals of 3 to 15 seconds in individuals with OSA. In healthy adults undergoing mild sleep restriction, a higher number of EEG-detected microarousals during sleep was significantly associated with lower levels of positive mood during the day. It was also linked to poorer performance on tasks measuring selective attention, particularly in disengagement and orientation. However, these associations varied depending on the duration threshold used to define microarousals, the time of testing, and the specific type of task performed.^[2]

Biological function

Microarousals (MAs) occur across mammalian species and have been identified as components of healthy sleep. However, they are observed most frequently in sleep disorders associated with physical discomfort or mental health conditions. The diagnostic relevance of MA frequency for adverse health outcomes has contributed to a predominant view of MAs as disruptive to sleep. This perspective has led to comparatively less attention on MAs in sleep physiology research, which has historically emphasized mechanisms that promote sleep and inhibit arousal. Although the neurobiological origins of MAs are not fully understood, recent rodent studies indicate that several wake-promoting brain regions remain active during sleep, generating MAs at specific times under particular brain-body states. These findings suggest that MAs may play a role in normal sleep dynamics, complementing the clinical perspective that primarily associates them with sleep disruption. To date, research on microarousals in rodents has primarily addressed a specific scientific question, providing insights that complement the clinical perspective that sleep fragmentation can reduce the restorative benefits of sleep.^[3]

Continuous sleep supports the restoration of the brain and body, while fragmented sleep has negative effects on cognition and overall health. Microarousals (MAs), brief intrusions into sleep typically lasting 3 to 15 seconds, serve as clinical indicators of various sleep disorders. Recent studies in rodents indicate that MAs occurring during healthy non-rapid eye movement (NREM) sleep are determined by infraslow fluctuations in noradrenaline (NA), which are coordinated with electrophysiological rhythms, vasomotor activity, cerebral blood volume, and glymphatic flow. These findings suggest that MAs are an integral part of normal sleep dynamics, highlighting potential biological functions.^[3]

Evidence indicates that MAs may support the benefits of NREM sleep associated with NA fluctuations, following an inverted U-shaped relationship. Reduced noradrenergic fluctuations, as can occur in neurodegenerative conditions or with certain sleep aids, are associated with fewer MAs, while heightened fluctuations, such as those caused by stress, can fragment NREM sleep and disrupt NA signaling. MAs are therefore considered important for the recuperative and pliability-fostering functions of sleep and provide insight into both normal and pathological arousal dynamics.^[3]

See also

• Microsleep

References

1. "What are Micro-Awakenings? The Causes of Night Wakings in Babies and How to Address the Root Cause". Omazz. 22 September 2025. Retrieved 1 March 2026.
2. Zhai, Diguo; Chen, Qingwei; Yao, Ying; Ru, Taotao; Zhou, Guofu (2024). "Association Between EEG Microarousal During Nocturnal Sleep and Next‑Day Selective Attention in Mild Sleep‑Restricted Healthy Undergraduates". Nature and Science of Sleep. 16: 335–344. doi:10.2147/NSS.S442007. PMC 10986413. PMID 38567117.
3. Lüthi, A; Nedergaard, M (2025). "Anything but small: Microarousals stand at the crossroad between noradrenaline signaling and key sleep functions". Neuron. doi:10.1016/j.neuron.2024.00887‑0 (inactive 28 February 2026).
4. Martin, SE; Engleman, HM; Kingshott, RN; Douglas, NJ (December 1997). "Microarousals in patients with sleep apnoea/hypopnoea syndrome". J Sleep Res. 6 (4): 276–280. doi:10.1111/j.1365-2869.1997.00276.x. PMID 9493529.